서울아이씨

비상장계속사업자

seoul international chemical

임창규

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

서울아이씨

Business Reg. No. 3038166929 · CEO 임창규

I.Investment Overview

Target서울아이씨 (3038166929)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명서울아이씨
영문명seoul international chemical
대표자임창규
사업자등록번호3038166929
법인등록번호1545110052574
설립일2012.07.01
종업원수44명

V.Workforce

44

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW264.82021297.92022272.72023285.12024313.82025
영업이익100M KRW6.9202111.120226.420236.320247.32025
순이익100M KRW720212.520223.920233.320243.82025
Item20252024202320222021
자산총계264.8억원268.6억원229.2억원238.3억원217.5억원
부채총계144.7억원148.3억원125.6억원135.1억원115.9억원
자본총계120.2억원120.3억원103.6억원103.2억원101.7억원
매출액313.8억원285.1억원272.7억원297.9억원264.8억원
영업이익7.3억원6.3억원6.4억원11.1억원6.9억원
순이익3.8억원3.3억원3.9억원2.5억원7억원

VII.Financial Ratios

FY2025 basis

2.33%

영업이익률

1.21%

순이익률

1.44%

ROA

3.17%

ROE

120.42%

부채비율

45.37%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

서울아이씨 투심보고서 | Alpha Lenz